TTNP icon

Titan Pharmaceuticals
TTNP

Overview Fund Activity

27 hedge funds and large institutions have $216K invested in Titan Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
4
Closed
2
Calls
$65K
Puts
$3K
Net Calls
+$62K
Net Calls Change
-$447K

Top Buyers

1
SM
1
Sabby Management
Florida
$22K
2
HF
2
HRT Financial
New York
$5K
3
Goldman Sachs
3
Goldman Sachs
New York
$3K
4
Bank of America
4
Bank of America
North Carolina
$2K

Top Sellers

1
ARTA
1
A.R.T. Advisors
New York
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$146K
4
VF
4
Virtu Financial
New York
$9K
5
WPA
5
Winning Points Advisors
Florida
$3K
Name Market Value Shares Shares
Change 		Shares
Change %
LF
26
Lee Financial
Texas
$0 167 – –
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$0 117 – –
LTFS
28
Ladenburg Thalmann Financial Services
Florida
$0 35 – –
BlackRock
29
BlackRock
New York
$0 1,838 – –
Fidelity Investments
30
Fidelity Investments
Massachusetts
$0 4 +4 New
Morgan Stanley
31
Morgan Stanley
New York
$0 573 +33 +6%
SFS
32
Sowell Financial Services
Arkansas
$0 562 +562 New
1
2